12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga·08/15/2025 21:22:47
Listen to the news
Gainers
- DIH Holding US (NASDAQ:DHAI) stock rose 52.0% to $0.36 during Friday's after-market session. The company's market cap stands at $10.5 million.
- Tonix Pharmaceuticals (NASDAQ:TNXP) stock increased by 17.76% to $60.33. The market value of their outstanding shares is at $438.3 million. As per the press release, Q2 earnings came out 4 days ago.
- BioXcel Therapeutics (NASDAQ:BTAI) stock moved upwards by 15.14% to $6.31. The company's market cap stands at $65.1 million. The company's, Q2 earnings came out 3 days ago.
- Adaptimmune Therapeutics (NASDAQ:ADAP) stock rose 14.28% to $0.07. The market value of their outstanding shares is at $19.3 million. As per the news, the Q2 earnings report came out 2 days ago.
- Propanc Biopharma Inc (NASDAQ:PPCB) stock increased by 12.41% to $3.35.
- Cuprina Holdings (Cayman) (NASDAQ:CUPR) stock increased by 9.24% to $1.3. The market value of their outstanding shares is at $69.2 million.
Losers
- Tivic Health Systems (NASDAQ:TIVC) stock fell 14.2% to $3.25 during Friday's after-market session. The company's market cap stands at $3.6 million. As per the news, the Q2 earnings report came out yesterday.
- CASI Pharmaceuticals (NASDAQ:CASI) stock fell 10.55% to $2.12. The company's market cap stands at $30.0 million.
- Vyome Holdings (NASDAQ:HIND) shares declined by 7.01% to $13.07.
- Co-Diagnostics (NASDAQ:CODX) shares declined by 6.36% to $0.28. The market value of their outstanding shares is at $8.9 million. The company's, Q2 earnings came out yesterday.
- Trinity Biotech (NASDAQ:TRIB) stock decreased by 5.56% to $1.53. The company's market cap stands at $36.6 million.
- Precigen (NASDAQ:PGEN) shares declined by 5.11% to $2.79. The market value of their outstanding shares is at $551.2 million. The company's, Q2 earnings came out 3 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.